Urology
Sr No. | Generic Name | Therapeutic Indications | Therapeutic class |
---|---|---|---|
1 | Cefaclor monohydrate USP eq. to Anhydrous Cefaclor 250mg suspension | Indicated for the treatment of various bacterial infections, including respiratory tract infections, otitis media, and urinary tract infections, caused by susceptible organisms. | Antibiotic |
2 | Alfuzosin 10mg Extended Release and Dutasteride 0.5mg Tablets | for the management of benign prostatic hyperplasia (BPH) in adult males, addressing both urinary symptoms and reducing the risk of acute urinary retention and surgery. | Reductase Inhibitor and Alpha-Blocker |
3 | Alfuzosin 10mg Prolonged Release Tablets | for the treatment of benign prostatic hyperplasia (BPH) to improve urinary symptoms and promote better urine flow. | Uroselective |
4 | Allopurinol USP 100 mg Tablet | Gout (increased uric acid in joints), Kidney stones, Bladder stones | Enzyme inhibitor |
5 | Capsules of Oxalobacter, Lactobacillus and Bifidobacterium with FOS | Supports urinary tract health by promoting a balanced microbiota, including Oxalobacter, Lactobacillus, and Bifidobacterium, along with prebiotic FOS (fructooligosaccharides). | Urobiotic |
6 | Cefadroxil monohydrate USP Equivalent to Cefadroxil 500 mg Capsule | Treat bacterial infections of the ear, nose, sinuses (sinusitis), throat (tonsillitis, pharyngitis), lungs (bronchitis, pneumonia), and urinary system (cystitis and kidney infections). | Antibiotic |
7 | Cefixime Trihydrate USP Equivalent to anhydrous Cefixime 200 / 400 mg Capsule | Indicated for the treatment of bacterial infections, including respiratory tract infections, urinary tract infections, and otitis media, caused by susceptible strains of microorganisms. | Antibiotic |
8 | Ceftriaxone sodium Injection 1000 mg Injection | Treatment of urinary tract infections (UTIs) caused by susceptible bacteria. | Treatment of Bactarial Infection |
9 | Cephalexin monohydrate USP Equivalent to anhydrous Cephalexinv 500 mg Capsule | Treat various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and urinary tract infections, caused by susceptible strains of microorganisms. | Antibiotic |
10 | Dutasteride 0.5 mg tablet | Improving urinary symptoms and reducing the risk of acute urinary retention and the need for surgery. | 5-Alpha Reductase Inhibitor |
11 | Dutasteride 0.5 mg Tablet + Silodosin 4/8 mg Tablet + Tadalafil 0.3 mg Tablet | Combination medication for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction. | Uroselective Therapy |
12 | Febuxostat 40 mg ER Tablets | Tablets are indicated for the management of hyperuricemia in patients with gout to reduce the formation and deposition of urate crystals in the urinary tract and joints. | Antigout in one line |
13 | Finasteride 1 mg | improve symptoms and reduce the risk of acute urinary retention and the need for surgical intervention. | 5-Alpha Reductase Inhibitor |
14 | L-carnitine 1000 mg, Ubidecarenone 60 mg, Zinc 12 mg and Lycopene 2500 mcg Tablets | This formulation maintaining urinary function and promoting a healthy prostate. | Uroprotective |
15 | Potassium Magnesium Citrate Tablets 978 mg & Potassium Magnesium Citrate with Vit B6 Solution 200 / 450ml | Prevention of kidney stones by promoting the excretion of citrate, potassium, and magnesium, and providing supplemental vitamin B6 for metabolic support in urology. | Urolithiasis-prophylaxis |
16 | Silodosin 4/8 mg Tablet | Relieve symptoms such as difficulty urinating, frequent or urgent urination, and incomplete emptying of the bladder, improving overall urinary flow and quality of life. | Alpha-blocker |
17 | Tamsulosin 0.4mg MR Tablets | for the treatment of benign prostatic hyperplasia (BPH) to relieve symptoms of urinary obstruction and improve urinary flow. It is an alpha-1 blocker that helps relax muscles in the prostate and bladder neck. | Alpha-blocker |
18 | Tamsulosin 0.4mg SR and Dutasteride 0.5 mg Capsules | Providing relief of lower urinary tract symptoms and reducing the risk of disease progression. | Inhibitor and Alpha-Blocker |